Staphylococcus lugdunensis - Not the Average Coagulase-Negative Staphylococcus Species

Kristi L. Frank, Robin Patel

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Staphylococcus lugdunensis is an unusually virulent coagulase-negative staphylococcal species with unique clinical and microbiological properties. S. lugdunensis is a skin commensal, as well as a pathogen with a propensity to cause highly aggressive and destructive infections that clinically resemble those caused by Staphylococcus aureus, including native valve endocarditis. Aside from endocarditis, S. lugdunensis infections include skin and soft tissue infection and prosthetic joint infection. Some isolates produce a membrane-bound form of coagulase that may result in misidentification of S. lugdunensis as S. aureus in the clinical laboratory. Unlike other coagulase-negative staphylococci, S. lugdunensis is usually susceptible to most antimicrobial agents, lacks mecA, and shares CLSI antimicrobial susceptibility breakpoints for oxacillin with S. aureus. The virulence factors that contribute to the heightened pathogenicity of S. lugdunensis remain largely undetermined. Recent studies indicate that S. lugdunensis can bind to host tissues or prosthetic surfaces and form biofilms.

Original languageEnglish (US)
Pages (from-to)55-62
Number of pages8
JournalClinical Microbiology Newsletter
Volume30
Issue number8
DOIs
StatePublished - Apr 15 2008

Fingerprint

Staphylococcus lugdunensis
Coagulase
Staphylococcus
Staphylococcus aureus
Endocarditis
Infection
Oxacillin
Skin
Soft Tissue Infections
Virulence Factors
Biofilms
Anti-Infective Agents
Virulence
Joints
Membranes

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Cite this

Staphylococcus lugdunensis - Not the Average Coagulase-Negative Staphylococcus Species. / Frank, Kristi L.; Patel, Robin.

In: Clinical Microbiology Newsletter, Vol. 30, No. 8, 15.04.2008, p. 55-62.

Research output: Contribution to journalArticle

@article{dcdaa67bc92e4d92aa1c2186b1cffe5b,
title = "Staphylococcus lugdunensis - Not the Average Coagulase-Negative Staphylococcus Species",
abstract = "Staphylococcus lugdunensis is an unusually virulent coagulase-negative staphylococcal species with unique clinical and microbiological properties. S. lugdunensis is a skin commensal, as well as a pathogen with a propensity to cause highly aggressive and destructive infections that clinically resemble those caused by Staphylococcus aureus, including native valve endocarditis. Aside from endocarditis, S. lugdunensis infections include skin and soft tissue infection and prosthetic joint infection. Some isolates produce a membrane-bound form of coagulase that may result in misidentification of S. lugdunensis as S. aureus in the clinical laboratory. Unlike other coagulase-negative staphylococci, S. lugdunensis is usually susceptible to most antimicrobial agents, lacks mecA, and shares CLSI antimicrobial susceptibility breakpoints for oxacillin with S. aureus. The virulence factors that contribute to the heightened pathogenicity of S. lugdunensis remain largely undetermined. Recent studies indicate that S. lugdunensis can bind to host tissues or prosthetic surfaces and form biofilms.",
author = "Frank, {Kristi L.} and Robin Patel",
year = "2008",
month = "4",
day = "15",
doi = "10.1016/j.clinmicnews.2008.03.004",
language = "English (US)",
volume = "30",
pages = "55--62",
journal = "Clinical Microbiology Newsletter",
issn = "0196-4399",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Staphylococcus lugdunensis - Not the Average Coagulase-Negative Staphylococcus Species

AU - Frank, Kristi L.

AU - Patel, Robin

PY - 2008/4/15

Y1 - 2008/4/15

N2 - Staphylococcus lugdunensis is an unusually virulent coagulase-negative staphylococcal species with unique clinical and microbiological properties. S. lugdunensis is a skin commensal, as well as a pathogen with a propensity to cause highly aggressive and destructive infections that clinically resemble those caused by Staphylococcus aureus, including native valve endocarditis. Aside from endocarditis, S. lugdunensis infections include skin and soft tissue infection and prosthetic joint infection. Some isolates produce a membrane-bound form of coagulase that may result in misidentification of S. lugdunensis as S. aureus in the clinical laboratory. Unlike other coagulase-negative staphylococci, S. lugdunensis is usually susceptible to most antimicrobial agents, lacks mecA, and shares CLSI antimicrobial susceptibility breakpoints for oxacillin with S. aureus. The virulence factors that contribute to the heightened pathogenicity of S. lugdunensis remain largely undetermined. Recent studies indicate that S. lugdunensis can bind to host tissues or prosthetic surfaces and form biofilms.

AB - Staphylococcus lugdunensis is an unusually virulent coagulase-negative staphylococcal species with unique clinical and microbiological properties. S. lugdunensis is a skin commensal, as well as a pathogen with a propensity to cause highly aggressive and destructive infections that clinically resemble those caused by Staphylococcus aureus, including native valve endocarditis. Aside from endocarditis, S. lugdunensis infections include skin and soft tissue infection and prosthetic joint infection. Some isolates produce a membrane-bound form of coagulase that may result in misidentification of S. lugdunensis as S. aureus in the clinical laboratory. Unlike other coagulase-negative staphylococci, S. lugdunensis is usually susceptible to most antimicrobial agents, lacks mecA, and shares CLSI antimicrobial susceptibility breakpoints for oxacillin with S. aureus. The virulence factors that contribute to the heightened pathogenicity of S. lugdunensis remain largely undetermined. Recent studies indicate that S. lugdunensis can bind to host tissues or prosthetic surfaces and form biofilms.

UR - http://www.scopus.com/inward/record.url?scp=41249101814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41249101814&partnerID=8YFLogxK

U2 - 10.1016/j.clinmicnews.2008.03.004

DO - 10.1016/j.clinmicnews.2008.03.004

M3 - Article

AN - SCOPUS:41249101814

VL - 30

SP - 55

EP - 62

JO - Clinical Microbiology Newsletter

JF - Clinical Microbiology Newsletter

SN - 0196-4399

IS - 8

ER -